I had blogged yesterday
on the setting aside of the Sutent revocation order, and lifting of injunction on
Cipla from manufacturing its drug Sunitinib.
Today, the
Indian Express has reported on lifting of the restraint on Cipla. The
news report, however, does not mention anything about setting aside of the
revocation order of the Sutent patent. I guess only a reading of the SC's order will clarify
the true position.
No comments:
Post a Comment